{
    "eid": "2-s2.0-85125469457",
    "title": "Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "atherosclerotic cardiovascular disease",
        "cardiac prevention",
        "cardiovascular health",
        "cardiovascular risk",
        "lifestyle modifications"
    ],
    "authors": [
        "Pamela S. Douglas",
        "Triin Umbleja",
        "Gerald S. Bloomfield",
        "Carl J. Fichtenbaum",
        "Markella V. Zanni",
        "Edgar T. Overton",
        "Kathleen V. Fitch",
        "Emma M. Kileel",
        "Judith A. Aberg",
        "Judith Currier",
        "Craig A. Sponseller",
        "Kathleen Melbourne",
        "Anchalee Avihingsanon",
        "Flavio Bustorff",
        "Vicente Estrada",
        "Kiat Ruxrungtham",
        "Maria Saumoy",
        "Ann Marie Navar",
        "Udo Hoffmann",
        "Heather J. Ribaudo",
        "Steven Grinspoon"
    ],
    "citedby-count": 12,
    "ref-count": 31,
    "ref-list": [
        "Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association",
        "HIV infection and the risk of acute myocardial infarction",
        "Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease",
        "Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis",
        "Application of a novel CD206+ macrophage-specific arterial imaging strategy in HIV-infected individuals",
        "Cardiovascular complications of HIV in endemic countries",
        "HIV and the heart: the impact of antiretroviral therapy: a global perspective",
        "HIV infection and primary prevention of cardiovascular disease: lights and shadows in the HAART Era",
        "Comorbidities in persons with HIV: the lingering challenge",
        "2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines",
        "Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association\u2019s strategic impact goal through 2020 and beyond",
        "Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: a meta-analysis",
        "Rationale and design of the randomized trial to prevent vascular events in HIV (REPRIEVE)",
        "2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines",
        "Development and evaluation of the nutrition component of the rapid eating and activity assessment for patients (REAP): a new tool for primary care providers",
        "Patterns of antiretroviral therapy use and immunologic profiles at enrollment in the REPRIEVE trial",
        "Inflammation, immune activation, and cardiovascular disease in HIV",
        "HIV protease inhibitors: a review of molecular selectivity and toxicity",
        "Recent abacavir use increases risk of type 1 and type 2 myocardial infarctions among adults with HIV",
        "Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet-collagen interactions",
        "No association of abacavir use with myocardial infarction: findings of an FDA meta-analysis",
        "Atherosclerotic cardiovascular disease risk profile of tenofovir alafenamide versus tenofovir disoproxil fumarate",
        "Arterial inflammation in patients with HIV",
        "Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men",
        "Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study",
        "Rationale and design of the mechanistic substudy of the randomized trial to prevent vascular events in HIV (REPRIEVE): effects of pitavastatin on coronary artery disease and inflammatory biomarkers",
        "Status of cardiovascular health in US adults: prevalence estimates from the national health and nutrition examination surveys (NHANES) 2003-2008",
        "Community prevalence of ideal cardiovascular health, by the American heart association definition, and relationship with cardiovascular disease incidence",
        "Impact of perceived cardiovascular risk on cardiovascular disease prevention behaviors in people with and without HIV infection",
        "The PROSPER-HIV study: a research protocol to examine relationships among physical activity, diet intake, and symptoms in adults living with HIV"
    ],
    "affiliation": [
        {
            "affiliation-city": "Rio de Janeiro",
            "@id": "60066842",
            "affilname": "Hospital Geral de Rio de Janeiro",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60066842",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Madrid",
            "@id": "60032461",
            "affilname": "Hospital Cl\u00ednico San Carlos",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032461",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Durham",
            "@id": "60030982",
            "affilname": "Duke Clinical Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030982",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60029929",
            "affilname": "Massachusetts General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029929",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Los Angeles",
            "@id": "60027550",
            "affilname": "University of California, Los Angeles",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027550",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Birmingham",
            "@id": "60027086",
            "affilname": "The University of Alabama at Birmingham",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027086",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Dallas",
            "@id": "60026695",
            "affilname": "UT Southwestern Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026695",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cincinnati",
            "@id": "60025152",
            "affilname": "University of Cincinnati",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025152",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New York",
            "@id": "60012981",
            "affilname": "Icahn School of Medicine at Mount Sinai",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012981",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "60011805",
            "affilname": "Hospital Universitari de Bellvitge",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011805",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60005478",
            "affilname": "Center for Biostatistics in AIDS Research",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005478",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Foster City",
            "@id": "60002909",
            "affilname": "Gilead Sciences Incorporated",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Kowa Pharmaceuticals America",
        "National Institutes of Health",
        "National Heart, Lung, and Blood Institute",
        "National Institute of Allergy and Infectious Diseases",
        "American Heart Association",
        "Gilead Sciences",
        "Columbia University",
        "Oregon Health and Science University"
    ]
}